EUROPEAN DISEASE INCIDENCE AND PREVALENCE

334 Pages | 92 Exhibits | 2008 Analysis Product Family: Market Reports




OVERVIEW:
Major diseases in Europe (from cancer and cardiovascular disease to neurologic and psychiatric disorders) take their toll in terms of lost days from work, hospital expenditures, and out-of-pocket costs. As the aging population in Europe increases and life spans lengthen, the incidence and prevalence of major diseases/disorders are expected to significantly impact the European healthcare industry.

This dynamic new report from Medtech Insight examines the etiology and epidemiology of the most prevalent and costly diseases/disorders in Europe such as Alzheimer's disease, anemia, arthritis, asthma, benign prostatic hyperplasia, bronchitis, burns/wounds, cancer, cataracts, depression, diabetes, emphysema, erectile dysfunction, glaucoma, heart failure, human immunodeficiency virus/acquired immune deficiency syndrome, hypertension, infertility, multiple sclerosis, osteoporosis, pneumonia, spongiform encephalopathy, and stroke.

In addition to the proprietary data from Medtech Insight's internal resources that are utilized in this report, many organizations have provided information including Alzheimer Europe, European Registries of Stroke Collaboration, Myasthenia Gravis Association, Organization for Economic Cooperation and Development, and the World Health Organization, among others.

TABLE OF CONTENTS:
INTRODUCTION

CHAPTER 1: EUROPEAN HEALTHCARE OVERVIEW	

	1.1	The European Union	
		1.1.1	Adoption of a Common Currency	
		1.1.2	The Aging Population	
	1.2	Selected European National Healthcare Profiles	
		1.2.1	France	
			1.2.1.1	Healthcare Organization and Reform	
			1.2.1.2	Hospital Services	
			1.2.1.3	Medical Device Reimbursement	
		1.2.2	Germany	
			1.2.2.1	Healthcare Organization and Reform	
			1.2.2.2	Hospital Services	
			1.2.2.3	Medical Device Reimbursement	
		1.2.3	Italy	
			1.2.3.1	Healthcare Organization and Reform	
			1.2.3.2	Hospital Services	
			1.2.3.3	Medical Device Reimbursements	
		1.2.4	Spain	
			1.2.4.1	Healthcare Organization and Reform	
			1.2.4.2	Hospital Services	
			1.2.4.3	Medical Device Reimbursement	
		1.2.5	United Kingdom
			1.2.5.1	Healthcare Organization and Reform	
			1.2.5.2	Hospital Services	
			1.2.5.3	Medical Device Reimbursement	
		1.2.6	Benelux Countries	
			1.2.6.1	Healthcare Organization and Reform	
			1.2.6.2	Hospital Services	
			1.2.6.3	Medical Device Reimbursement	
		1.2.7	Nordic Countries	
			1.2.7.1	Healthcare Organization and Reform	
			1.2.7.2	Hospital Services	
			1.2.7.3	Medical Device Reimbursement	

	Exhibit 1-1:	European Union, Population Statistics Comparison for the Years 1996, 2006, and 2016	
	Exhibit 1-2:	France, Selected National Healthcare Statistics	
	Exhibit 1-3:	Germany, Selected National Healthcare Statistics
	Exhibit 1-4:	Italy, Selected National Healthcare Statistics	
	Exhibit 1-5:	Spain, Selected National Healthcare Statistics	
	Exhibit 1-6:	The United Kingdom, Selected National Healthcare Statistics	
	Exhibit 1-7:	Belgium, Selected National Healthcare Statistics	
	Exhibit 1-8:	The Netherlands, Selected National Healthcare Statistics	
	Exhibit 1-9:	Luxembourg, Selected National Healthcare Statistics	
	Exhibit 1-10: Denmark, Selected National Healthcare Statistics	
	Exhibit 1-11: Finland, Selected National Healthcare Statistics	
	Exhibit 1-12: Iceland, Selected National Healthcare Statistics	
	Exhibit 1-13: Norway, Selected National Healthcare Statistics	
	Exhibit 1-14: Sweden, Selected National Healthcare Statistics	

CHAPTER 2: BLOOD DISORDERS:  ANEMIA AND HEMOPHILIA	

	2.1	Anemia
		2.1.1	Iron Deficiency Anemia	
			2.1.1.1	Etiology	
			2.1.1.2	Epidemiology	
		2.1.2	Sickle Cell Anemia	
			2.1.2.1	Etiology	
			2.1.2.2	Epidemiology	
		2.1.3	Thalassemia	
			2.1.3.1	Etiology	
			2.1.3.2	Epidemiology	
	2.2	Hemophilia	
		2.2.1	Etiology	
		2.2.2	Epidemiology	

	Exhibit 2-1:	Europe, Iron Deficiency Anemia, Incidence and Prevalence, by Country	
	Exhibit 2-2:	Europe, Sickle Cell Anemia, Incidence and Prevalence, by Country	
	Exhibit 2-3:	Europe, Thalassemia, Prevalence, by Country	
	Exhibit 2-4:	Europe, Hemophilia, Incidence and Prevalence, by Country	

CHAPTER 3: CANCER
	
	3.1	Bladder Cancer	
		3.1.1	Etiology	
		3.1.2	Epidemiology	
	3.2	Brain Tumors
		3.2.1	Etiology	
		3.2.2	Epidemiology	
	3.3	Breast Cancer	
		3.3.1	Etiology	
		3.3.2	Epidemiology	
	3.4	Cervical/Uterine Cancer	
		3.4.1	Etiology	
		3.4.2	Epidemiology	
	3.5	Colon/Rectal Cancer	
		3.5.1	Etiology	
		3.5.2	Epidemiology	
	3.6	Leukemia	
		3.6.1	Etiology	
		3.6.2	Epidemiology	
	3.7	Lung Cancer	
		3.7.1	Etiology	
		3.7.2	Epidemiology	
	3.8	Lymphoma	
		3.8.1	Etiology	
		3.8.2	Epidemiology	
	3.9	Melanoma	
		3.9.1	Etiology
		3.9.2	Epidemiology	
	3.10	Oral Cancer	
		3.10.1	Etiology	
		3.10.2	Epidemiology	
	3.11	Ovarian Cancer	
		3.11.1	Etiology	
		3.11.2	Epidemiology	
	3.12	Pancreatic Cancer	
		3.12.1	Etiology	
		3.12.2	Epidemiology	
	3.13	Prostate Cancer
		3.13.1	Etiology	
		3.13.2	Epidemiology	
	3.14	Stomach Cancer	
		3.14.1	Etiology	
		3.14.2	Epidemiology	
	3.15	Testicular Cancer	
		3.15.1	Etiology	
		3.15.2	Epidemiology	

	Exhibit 3-1:	Europe, Bladder Cancer, Incidence, by Country	
	Exhibit 3-2:	Europe, Brain Tumors, Incidence and Prevalence, by Country	
	Exhibit 3-3:	Europe, Breast Cancer, Incidence, by Country	
	Exhibit 3-4:	Europe, Cervical/Uterine Cancer, Incidence, by Country
	Exhibit 3-5:	Europe, Colon/Rectal Cancer, Incidence, by Country	
	Exhibit 3-6:	Europe, Leukemia, Incidence, by Country
	Exhibit 3-7: Europe, Lung Cancer, Incidence, by Country	
	Exhibit 3-8: Europe, Lymphoma, Incidence, by Country
	Exhibit 3-9: Europe, Melanoma, Incidence, by Country	
	Exhibit 3-10: Europe, Oral Cancer, Incidence and Prevalence, by Country
	Exhibit 3-11: Europe, Ovarian Cancer, Incidence and Prevalence, by Country
	Exhibit 3-12: Pancreatic Cancer, Treatment Options and Survival Rates, by Stage	
	Exhibit 3-13: Europe, Pancreatic Cancer, Incidence, by Country	
	Exhibit 3-14: Europe, Prostate Cancer, Incidence, by Country	
	Exhibit 3-15: Europe, Stomach Cancer, Incidence, by Country	
	Exhibit 3-16: Europe, Testicular Cancer, Incidence, by Country	

CHAPTER 4: CARDIOVASCULAR DISORDERS
	
	4.1	Cardiac Arrhythmia	
		4.1.1	Etiology	
		4.1.2	Epidemiology	
	4.2	Heart Failure	
		4.2.1	Etiology	
		4.2.2	Epidemiology	
	4.3	Heart Valve Disorders	
		4.3.1	Etiology	
		4.3.2	Epidemiology	
	4.4	Hypertension	
		4.4.1	Etiology	
		4.4.2	Epidemiology	
	4.5	Vascular Disorders	
		4.5.1	Aneurysm	
			4.5.1.1	Etiology	
			4.5.1.2	Epidemiology
		4.5.2	Atherosclerosis	
			4.5.2.1	Etiology	
			4.5.2.2	Epidemiology	
		4.5.3	Ischemic Heart Disease	
			4.5.3.1	Etiology	
			4.5.3.2	Epidemiology	
		4.5.4	Myocardial Infarction	
			4.5.4.1	Etiology	
			4.5.4.2	Epidemiology	
		4.5.5	Peripheral Vascular Disease	
			4.5.5.1	Etiology	
			4.5.5.2	Epidemiology	

	Exhibit 4-1:	Europe, Cardiac Arrhythmia, Prevalence, by Country	
	Exhibit 4-2:	Europe, Heart Failure, Incidence and Prevalence, by Country	
	Exhibit 4-3:	Europe, Heart Valve Disorders, Incidence and Prevalence, by Country	
	Exhibit 4-4:	Europe, Hypertension, Incidence and Prevalence, by Country	
	Exhibit 4-5:	Europe, Aneurysm, Prevalence, by Country	
	Exhibit 4-6:	Europe, Atherosclerosis, Prevalence, by Country	
	Exhibit 4-7:	Europe, Ischemic Heart Disease, Prevalence, by Country	
	Exhibit 4-8:	Europe, Myocardial Infarction, Incidence and Prevalence, by Country
	Exhibit 4-9:	Europe, Peripheral Vascular Disease, Prevalence, by Country	

CHAPTER 5: METABOLIC DISORDERS	

	5.1	Cholelithiasis	
		5.1.1	Etiology	
		5.1.2	Epidemiology	
	5.2	Chronic Kidney Disease/End-Stage Renal Disease	
		5.2.1	Etiology	
		5.2.2	Epidemiology	
	5.3	Diabetes	
		5.3.1	Etiology	
		5.3.2	Epidemiology	
	5.4	Urolithiasis	
		5.4.1	Etiology	
		5.4.2	Epidemiology	

	Exhibit 5-1:	Europe, Cholelithiasis, Incidence and Prevalence, by Country
	Exhibit 5-2:	Europe, End-Stage Renal Disease, Incidence and Prevalence, by Country
	Exhibit 5-3:	Europe, Diabetes, Incidence and Prevalence, by Country	
	Exhibit 5-4:	Europe, Urolithiasis, Incidence and Prevalence, by Country	

CHAPTER 6: MUSCULOSKELETAL DISORDERS	

	6.1	Arthritis	
		6.1.1	Etiology	
		6.1.2	Epidemiology	
	6.2	Carpal Tunnel Syndrome	
		6.2.1	Etiology	
		6.2.2	Epidemiology	
	6.3	Meniscal and Ligament/Tendon Injuries	
		6.3.1	Etiology	
		6.3.2	Epidemiology	
	6.4	Duchenne Muscular Dystrophy
		6.4.1	Etiology	
		6.4.2	Epidemiology	
	6.5	Osteoporosis	
		6.5.1	Etiology	
		6.5.2	Epidemiology	

	Exhibit 6-1:	Europe, Arthritis, Incidence and Prevalence, by Country	
	Exhibit 6-2:	Europe, Carpel Tunnel Syndrome, Incidence and Prevalence, by Country	
	Exhibit 6-3:	Europe, Meniscal and Ligament/Tendon Injuries, Incidence, by Country	
	Exhibit 6-4:	Europe, Duchenne Muscular Dystrophy, Incidence and Prevalence, by Country	
	Exhibit 6-5:	Europe, Osteoporosis, Incidence and Prevalence, by Country	

CHAPTER 7: NEUROLOGIC AND PSYCHIATRIC DISORDERS	

	7.1	Alzheimer's Disease	
		7.1.1	Etiology	
		7.1.2	Epidemiology	
	7.2	Amyotrophic Lateral Sclerosis	
		7.2.1	Etiology	
		7.2.2	Epidemiology	
	7.3	Bipolar Disorder	
		7.3.1	Etiology	
		7.3.2	Epidemiology	
	7.4	Cerebrovascular Disorders	
		7.4.1	Arteriovenous Malformation	
			7.4.1.1	Etiology	
			7.4.1.2	Epidemiology	
		7.4.2	Stroke	
			7.4.2.1	Etiology	
			7.4.2.3	Epidemiology	
	7.5	Depression	
		7.5.1	Etiology	
		7.5.2	Epidemiology	
	7.6	Epilepsy	
		7.6.1	Etiology	
		7.6.2	Epidemiology	
	7.7	Huntington's Disease	
		7.7.1	Etiology	
		7.7.2	Epidemiology
	7.8	Hydrocephalus	
		7.8.1	Etiology	
		7.8.2	Epidemiology	
	7.9	Multiple Sclerosis	
		7.9.1	Etiology	
		7.9.2	Epidemiology	
	7.10	Myasthenia Gravis	
		7.10.1	Etiology	
		7.10.2	Epidemiology
	7.11	Parkinson's Disease	
		7.11.1	Etiology	
		7.11.2	Epidemiology	
	7.12	Schizophrenia	
		7.12.1	Etiology	
		7.12.2	Epidemiology	

	Exhibit 7-1:	Diagnosed Alzheimer's Disease Population	
	Exhibit 7-2:	Europe, Alzheimer's Disease, Incidence and Prevalence, by Country
	Exhibit 7-3:	Europe, Amyotrophic Lateral Sclerosis, Incidence and Prevalence, by Country	
	Exhibit 7-4:	Europe, Bipolar Disorder, Prevalence, by Country	
	Exhibit 7-5:	Europe, Arteriovenous Malformation, Incidence and Prevalence, by Country	
	Exhibit 7-6:	Europe, Stroke, Incidence and Prevalence, by Country	
	Exhibit 7-7:	Europe, Depression, Prevalence, by Country	
	Exhibit 7-8:	Europe, Epilepsy, Incidence and Prevalence, by Country	
	Exhibit 7-9:	Europe, Huntington's Disease, Incidence and Prevalence, by Country	
	Exhibit 7-10: Europe, Multiple Sclerosis, Incidence and Prevalence, by Country	
	Exhibit 7-11: Europe, Myasthenia Gravis, Prevalence, by Country	
	Exhibit 7-12: Europe, Parkinson's Disease, Incidence and Prevalence, by Country	
	Exhibit 7-13: Europe, Schizophrenia, Prevalence, by Country	


CHAPTER 8: OPHTHALMIC DISORDERS:  CATARACTS AND GLAUCOMA
	
	8.1	Cataracts	
		8.1.1	Etiology	
		8.1.2	Epidemiology	
	8.2	Glaucoma	
		8.2.1	Etiology	
		8.2.2	Epidemiology	

	Exhibit 8-1:	Europe, Cataracts, Incidence and Prevalence, by Country	
	Exhibit 8-2:	Europe, Glaucoma, Incidence and Prevalence, by Country	

CHAPTER 9: REPRODUCTIVE AND GENITOURINARY DISORDERS
	
	9.1	Benign Prostatic Hyperplasia	
		9.1.1	Etiology	
		9.1.2	Epidemiology	
	9.2	Endometriosis	
		9.2.1	Etiology	
		9.2.2	Epidemiology	
	9.3	Erectile Dysfunction	
		9.3.1	Etiology	
		9.3.2	Epidemiology	
	9.4	Infertility	
		9.4.1	Etiology	
		9.4.2	Epidemiology	
	9.5	Urinary Incontinence	
		9.5.1	Etiology	
		9.5.2	Epidemiology	

	Exhibit 9-1:	Europe, Benign Prostatic Hyperplasia, Incidence and Prevalence, by Country	
	Exhibit 9-2:	Europe, Endometriosis, Prevalence, by Country
	Exhibit 9-3:	Europe, Erectile Dysfunction, Incidence and Prevalence, by Country	
	Exhibit 9-4:	Europe, Infertility, Incidence and Prevalence, by Country	
	Exhibit 9-5:	Europe, Urinary Incontinence, Incidence and Prevalence, by Country	

CHAPTER 10: RESPIRATORY DISORDERS	

	10.1	Adult Respiratory Distress Syndrome	
		10.1.1	Etiology	
		10.1.2	Epidemiology	
	10.2	Apnea	
		10.2.1	Etiology	
		10.2.2	Epidemiology	
	10.3	Asthma	
		10.3.1	Etiology	
		10.3.2	Epidemiology	
	10.4	Cystic Fibrosis	
		10.4.1	Etiology	
		10.4.2	Epidemiology	
	10.5	Emphysema	
		10.5.1	Etiology	
		10.5.2	Epidemiology	
	10.6	Pneumothorax	
		10.6.1	Etiology	
		10.6.2	Epidemiology
	10.7	Respiratory Failure	
		10.7.1	Etiology	
		10.7.2	Epidemiology	
	10.8	Restrictive Pulmonary Disease	
		10.8.1	Etiology	
	10.8.2	Epidemiology	

	Exhibit 10-1: Europe, Adult Respiratory Distress Syndrome, Incidence and Prevalence, by Country	
	Exhibit 10-2: Europe, Apnea, Incidence and Prevalence, by Country	
	Exhibit 10-3: Europe, Asthma, Incidence and Prevalence, by Country	
	Exhibit 10-4: Europe, Cystic Fibrosis, Incidence and Prevalence, by Country	
	Exhibit 10-5: Europe, Emphysema, Prevalence, by Country	
	Exhibit 10-6: Europe, Pneumothorax, Incidence and Prevalence, by Country	
	Exhibit 10-7: Europe, Respiratory Failure, Incidence, by Country	
	Exhibit 10-8: Europe, Restrictive Pulmonary Disease, Prevalence, by Country	

CHAPTER 11: WOUNDS
	
	11.1	Diabetic Ulcers	
		11.1.1	Etiology	
		11.1.2	Epidemiology	
	11.2	Pressure Ulcers	
		11.2.1	Etiology	
		11.2.2	Epidemiology	
	11.3	Surgical Wounds	
		11.3.1	Etiology	
		11.3.2	Epidemiology
	11.4	Traumatic Wounds	
		11.4.1	Etiology	
			11.4.1.1	Amputation	
			11.4.1.2	Burns	
			11.4.1.3	Lacerations, Contusions, and Abrasions	
		11.4.2	Epidemiology	

	Exhibit 11-1: Europe, Diabetic Ulcers, Incidence, by Country	
	Exhibit 11-2: Europe, Pressure Ulcers, Incidence, by Country	
	Exhibit 11-3: Europe, Surgical Wounds, Incidence, by Country	
	Exhibit 11-4: Classification of Burns, by Mechanism of Injury	
	Exhibit 11-5: Europe, Traumatic Wounds, Incidence, by Country	

CHAPTER 12: SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS	

	12.1	Bronchitis
		12.1.1	Etiology	
		12.1.2	Epidemiology	
	12.2	Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome	
		12.2.1	Etiology	
		12.2.2	Epidemiology	
	12.3	Pneumonia	
		12.3.2	Etiology	
		12.3.1	Epidemiology	
	12.4	Transmissible Spongiform Encephalopathies	
		12.4.1	Etiology	
		12.4.1	Epidemiology	
	12.5	Tuberculosis	
		12.5.1	Etiology	
		12.5.2	Epidemiology	

	Exhibit 12-1: Europe, Bronchitis, Prevalence, by Country	
	Exhibit 12-2: Acquired Immune Deficiency Syndrome, Indicator Diseases	
	Exhibit 12-3: European Union, Newly Diagnosed Human Immunodeficiency Virus Infections and Rates per One Million Population, by Selected Country	
	Exhibit 12-4: Europe, Human Immunodeficiency Virus, Incidence and Prevalence, by Country	
	Exhibit 12-5: Europe, Pneumonia, Incidence, by Country	
	Exhibit 12-6: Europe, Transmissible Spongiform Encephalopathies, Incidence, by Country	
	Exhibit 12-7: Europe, Tuberculosis, Incidence, by Country


Contact Us

Need help finding medtech research? Let us help you!